A question for you or anyone else that be informed on such matters. Obviously the lack of a launch costs RMTI some time and money but who is on the hook for the bad product? If RMTI it's costing them even more money. I wonder how much product we are talking about?
This is not a soft bash. I'm just curious.
I wish the longs well here as you have had more than enough patience. It seems like every time in the past when things start to really line up technically, fundamental bad news has hurt the stock.
I hope with earnings and any announcements around earnings that tide will work in reverse.
Looks like they are taking this down even more aggressively than the ETFs.
Is this a little birdie singing? I cant believe this much reaction is coming out of today's call. A modest volume bleed down.
I sold out of the last shares I had at a loss. Not ideal timing but otherwise occupied and I was trying to raise some cash.
I may reenter for a trade at any time. Maybe you'll get positive CMS information while I'm out which will certainly lift the shares.
You're probably right. I hope when they get the news from CMS on the 106% reimbursement on triferic for 2 years, good or bad that they release it
Thanks for your thoughts on the techinicals while not sugar coating things. That's simply called being honest.
The problem here is that it happens and happens and happens in the relatively short time I have followed the company.
I'm thankful my position is small but also kick myself for not taking even that off when it was green but didn't want to be left with no position for any positive news, particularly on Triferic. At least I had taken some trading profits previously.
Hopefully, the old adage of it's always darkest before the dawn holds but hope is generally not a good investment thesis.
If they effed up the CEO and RMTI effed up. The buck stops at the top of the food chain.
For all of you the CEO does no wrong folks, feel free to comment.
They'll put out a PR when they set a date. If you are in individual stocks you should know this.
Looks like without a positive word on the CMS 106% reimbursement on Triferic, this will be under pressure.
Without it the CC has another chance to be another exit stage left call by the CEO.
First off I do agree they have to manage their finances better. It's kind of over the top.
Secondly, it's better to have the debt offering in place for ongoing business and for the purposes of any negotiations IMHO.
Unfortunately RMTI have put it on a slow track for actual sales but below are known catalysts for the stock:
They already checked off one box by getting the powder form approved.
If they can get CMS to approve the 2 year 106% reimbursement we all know that could/should be huge.
Get Calcitriol commercially launched in the US but please explain what that means in terms of uptake (SEE AMBULANCE chasers).
More overseas deals/partnerships announced potentially in 2016.
Other deals or partnerships or general color on existing relationships.
If you want to be skeptic you say it starts to tank before if the data is bad and vice versa if the data is ultimately good.
Honestly, in this algo driven market flip a coin because anyone that tells you they know with any conviction either knows something or is running the algos.
We could certainly see disappointing data in a few weeks and you better believe the folks who love to manipulate stocks will slam this. That seems to be how things are these days. Even though as Michael alluded to you can make the case this is a nice investment based on the pain med alone, controlling shares with the aid of algos seems to be all the rage.